To view or add a comment, sign in 736 followers
Given currently inadequate evidence to support that COVID-19 patients with G6PD deficiency have a worse prognosis in terms of mortality, severity, and rate of hospitalization [11], a larger scale study should be performed that encompasses different ages, ethnicity, gender, and more importantly the disease-alleles (hemizygous, homozygous or heterozygous) with consideration of G6PD deficiency variants
And if youre curious how CJC-1295 stacks against other peptides (like the targeted fat-burner AOD-9604 mentioned earlier)
This chapter should be cited as follows: Hull ML, Nguyen TT, et al
In this case, you may not feel any overt symptoms, but you can still have elevated homocysteine or methylmalonic acid levels in your body